Global Interferon Injection Market Growth 2024-2030

Publication ID:

LPI07240286

Publication Date:

July 5, 2024

Pages:

134

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Interferons are proteins that are part of your natural defenses. They tell your immune system that germs or cancer cells are in your body. Interferon injection is a broad-spectrum antiviral agent that does not directly kill or inhibit viruses, but uses cell surface receptors to cause cells to produce antiviral proteins, thereby inhibiting virus replication. Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin鈥檚 lymphoma, and autoimmune diseases such as multiple sclerosis.
The global Interferon Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淚nterferon Injection Industry Forecast鈥� looks at past sales and reviews total world Interferon Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Interferon Injection sales for 2024 through 2030. With Interferon Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interferon Injection industry.
This Insight Report provides a comprehensive analysis of the global Interferon Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interferon Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Interferon Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interferon Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interferon Injection.
United States market for Interferon Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Interferon Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Interferon Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Interferon Injection players cover Roche, Bayer, Novartis, Biogen, Merck KGaA, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Interferon Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Long-acting Interferon Injection
Short-acting Interferon Injection
Segmentation by Application:
Hepatitis
Multiple Sclerosis
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Roche
Bayer
Novartis
Biogen
Merck KGaA
Zydus Cadila
Anhui Anke Biotechnology
Beijing Tri-Prime Gene Pharmaceutical
Beijing Kawin Technology
Shan Dong Kexing Biopharm
Shanghai Huaxin High Biotechnology
Harbin Pharmaceutical Group
Xiamen Amoytop Biotech
Sinobioway Biomedicine
3SBio Group
Changchun Heber Biological Technology
Key Questions Addressed in this Report
What is the 10-year outlook for the global Interferon Injection market?
What factors are driving Interferon Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interferon Injection market opportunities vary by end market size?
How does Interferon Injection break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interferon Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Interferon Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Interferon Injection by Country/Region, 2019, 2023 & 2030
2.2 Interferon Injection Segment by Type
2.2.1 Long-acting Interferon Injection
2.2.2 Short-acting Interferon Injection
2.3 Interferon Injection Sales by Type
2.3.1 Global Interferon Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Interferon Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Interferon Injection Sale Price by Type (2019-2024)
2.4 Interferon Injection Segment by Application
2.4.1 Hepatitis
2.4.2 Multiple Sclerosis
2.4.3 Others
2.5 Interferon Injection Sales by Application
2.5.1 Global Interferon Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Interferon Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Interferon Injection Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Interferon Injection Breakdown Data by Company
3.1.1 Global Interferon Injection Annual Sales by Company (2019-2024)
3.1.2 Global Interferon Injection Sales Market Share by Company (2019-2024)
3.2 Global Interferon Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Interferon Injection Revenue by Company (2019-2024)
3.2.2 Global Interferon Injection Revenue Market Share by Company (2019-2024)
3.3 Global Interferon Injection Sale Price by Company
3.4 Key Manufacturers Interferon Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interferon Injection Product Location Distribution
3.4.2 Players Interferon Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Interferon Injection by Geographic Region
4.1 World Historic Interferon Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Interferon Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Interferon Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Interferon Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Interferon Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Interferon Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Interferon Injection Sales Growth
4.4 APAC Interferon Injection Sales Growth
4.5 Europe Interferon Injection Sales Growth
4.6 Middle East & Africa Interferon Injection Sales Growth
5 Americas
5.1 Americas Interferon Injection Sales by Country
5.1.1 Americas Interferon Injection Sales by Country (2019-2024)
5.1.2 Americas Interferon Injection Revenue by Country (2019-2024)
5.2 Americas Interferon Injection Sales by Type (2019-2024)
5.3 Americas Interferon Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interferon Injection Sales by Region
6.1.1 APAC Interferon Injection Sales by Region (2019-2024)
6.1.2 APAC Interferon Injection Revenue by Region (2019-2024)
6.2 APAC Interferon Injection Sales by Type (2019-2024)
6.3 APAC Interferon Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Interferon Injection by Country
7.1.1 Europe Interferon Injection Sales by Country (2019-2024)
7.1.2 Europe Interferon Injection Revenue by Country (2019-2024)
7.2 Europe Interferon Injection Sales by Type (2019-2024)
7.3 Europe Interferon Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Interferon Injection by Country
8.1.1 Middle East & Africa Interferon Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Interferon Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Interferon Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Interferon Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interferon Injection
10.3 Manufacturing Process Analysis of Interferon Injection
10.4 Industry Chain Structure of Interferon Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interferon Injection Distributors
11.3 Interferon Injection Customer
12 World Forecast Review for Interferon Injection by Geographic Region
12.1 Global Interferon Injection Market Size Forecast by Region
12.1.1 Global Interferon Injection Forecast by Region (2025-2030)
12.1.2 Global Interferon Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Interferon Injection Forecast by Type (2025-2030)
12.7 Global Interferon Injection Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Interferon Injection Product Portfolios and Specifications
13.1.3 Roche Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Interferon Injection Product Portfolios and Specifications
13.2.3 Bayer Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Interferon Injection Product Portfolios and Specifications
13.3.3 Novartis Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Biogen
13.4.1 Biogen Company Information
13.4.2 Biogen Interferon Injection Product Portfolios and Specifications
13.4.3 Biogen Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Biogen Main Business Overview
13.4.5 Biogen Latest Developments
13.5 Merck KGaA
13.5.1 Merck KGaA Company Information
13.5.2 Merck KGaA Interferon Injection Product Portfolios and Specifications
13.5.3 Merck KGaA Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Merck KGaA Main Business Overview
13.5.5 Merck KGaA Latest Developments
13.6 Zydus Cadila
13.6.1 Zydus Cadila Company Information
13.6.2 Zydus Cadila Interferon Injection Product Portfolios and Specifications
13.6.3 Zydus Cadila Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Zydus Cadila Main Business Overview
13.6.5 Zydus Cadila Latest Developments
13.7 Anhui Anke Biotechnology
13.7.1 Anhui Anke Biotechnology Company Information
13.7.2 Anhui Anke Biotechnology Interferon Injection Product Portfolios and Specifications
13.7.3 Anhui Anke Biotechnology Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Anhui Anke Biotechnology Main Business Overview
13.7.5 Anhui Anke Biotechnology Latest Developments
13.8 Beijing Tri-Prime Gene Pharmaceutical
13.8.1 Beijing Tri-Prime Gene Pharmaceutical Company Information
13.8.2 Beijing Tri-Prime Gene Pharmaceutical Interferon Injection Product Portfolios and Specifications
13.8.3 Beijing Tri-Prime Gene Pharmaceutical Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Beijing Tri-Prime Gene Pharmaceutical Main Business Overview
13.8.5 Beijing Tri-Prime Gene Pharmaceutical Latest Developments
13.9 Beijing Kawin Technology
13.9.1 Beijing Kawin Technology Company Information
13.9.2 Beijing Kawin Technology Interferon Injection Product Portfolios and Specifications
13.9.3 Beijing Kawin Technology Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Beijing Kawin Technology Main Business Overview
13.9.5 Beijing Kawin Technology Latest Developments
13.10 Shan Dong Kexing Biopharm
13.10.1 Shan Dong Kexing Biopharm Company Information
13.10.2 Shan Dong Kexing Biopharm Interferon Injection Product Portfolios and Specifications
13.10.3 Shan Dong Kexing Biopharm Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shan Dong Kexing Biopharm Main Business Overview
13.10.5 Shan Dong Kexing Biopharm Latest Developments
13.11 Shanghai Huaxin High Biotechnology
13.11.1 Shanghai Huaxin High Biotechnology Company Information
13.11.2 Shanghai Huaxin High Biotechnology Interferon Injection Product Portfolios and Specifications
13.11.3 Shanghai Huaxin High Biotechnology Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai Huaxin High Biotechnology Main Business Overview
13.11.5 Shanghai Huaxin High Biotechnology Latest Developments
13.12 Harbin Pharmaceutical Group
13.12.1 Harbin Pharmaceutical Group Company Information
13.12.2 Harbin Pharmaceutical Group Interferon Injection Product Portfolios and Specifications
13.12.3 Harbin Pharmaceutical Group Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Harbin Pharmaceutical Group Main Business Overview
13.12.5 Harbin Pharmaceutical Group Latest Developments
13.13 Xiamen Amoytop Biotech
13.13.1 Xiamen Amoytop Biotech Company Information
13.13.2 Xiamen Amoytop Biotech Interferon Injection Product Portfolios and Specifications
13.13.3 Xiamen Amoytop Biotech Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Xiamen Amoytop Biotech Main Business Overview
13.13.5 Xiamen Amoytop Biotech Latest Developments
13.14 Sinobioway Biomedicine
13.14.1 Sinobioway Biomedicine Company Information
13.14.2 Sinobioway Biomedicine Interferon Injection Product Portfolios and Specifications
13.14.3 Sinobioway Biomedicine Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Sinobioway Biomedicine Main Business Overview
13.14.5 Sinobioway Biomedicine Latest Developments
13.15 3SBio Group
13.15.1 3SBio Group Company Information
13.15.2 3SBio Group Interferon Injection Product Portfolios and Specifications
13.15.3 3SBio Group Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 3SBio Group Main Business Overview
13.15.5 3SBio Group Latest Developments
13.16 Changchun Heber Biological Technology
13.16.1 Changchun Heber Biological Technology Company Information
13.16.2 Changchun Heber Biological Technology Interferon Injection Product Portfolios and Specifications
13.16.3 Changchun Heber Biological Technology Interferon Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Changchun Heber Biological Technology Main Business Overview
13.16.5 Changchun Heber Biological Technology Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂